What Is Biomarker Testing for Lung Cancer?
Biomarker testing is the evaluation of samples of a patient’s tumor, blood, or both to identify the genetic mutations responsible
cancer news and articles
from rcca
cancer news and articles
from rcca
We’re here for you. Call us at 844-346-7222 or
Results
Radiopharmaceuticals for Advanced Prostate Cancer: Precision Medicine at Work
Medical research has made tremendous strides in improving how oncologists understand and treat cancer. One of the most exciting developments
How Quickly Does Prostate Cancer Spread?
Prostate cancer is a common and fairly complex disease. Though it typically grows very slowly, there are times when prostate
What You Should Know About Lymphedema and How to Manage It
Lymphedema is a side effect of certain cancer treatments. Though uncommon, it is painful and can impact a person’s quality
Lumpectomy or Mastectomy? What You Need to Know
Breast cancer treatment options vary from patient to patient. Physicians must weigh many factors when considering which approach is best
Understanding the Latest Prostate Cancer Drugs
Prostate cancer treatments are constantly improving. Groundbreaking new medications provide longer survival and fewer side effects than ever before. Keeping
Increased Survival in Colorectal Cancer
Increased Survival in Colorectal Cancer: RCCA Oncologists Tell How Doctors &Patients Are Driving the Trend The colorectal cancer death rate has
American Cancer Society Honors Dr. May Abdo-Matkiwsky
RCCA’s Dr. May Abdo-Matkiwky Receives Prestigious Recognition at American Cancer Society’s Diamond Ball Regional Cancer Care Associates (RCCA) is dedicated
Self-Collection for HPV Testing Provides More Accessibility for Cervical Cancer Screening
Cervical cancer is most treatable when it is caught in its early stages. Routine screening can alert patients to cancer
we are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.